Investment
Features
FeesSafety
Academy
More
Pluang+

Coherent and Lumentum shares drop sharply as investors take profits before earnings reports.

Market News
10 Aug 2026
24/7 Wall Street
View Source
Bearish
pluang ai news

Shares of Coherent and Lumentum fell 12% and 7% respectively after strong multi-week gains driven by AI optics demand and U.S. export restrictions on Chinese transceivers. The pullback is mainly profit-taking and caution ahead of their upcoming fiscal Q4 2026 earnings reports on August 11 and 12. Valuations are very high, with P/E ratios above 140, pricing in strong growth tied to NVIDIA's AI data center expansion. Investors are watching these earnings closely for signs of sustained AI spending or potential supply-chain risks. Other optics players like Applied Optoelectronics, which already reported earnings, saw less impact. The broader semiconductor sector remains relatively stable, indicating the sell-off is optics-specific rather than a general chip market decline.

More News

Varex Imaging beats EPS estimates by 40% despite revenue miss amid $1.1B Teledyne acquisition.

Varex Imaging beats EPS estimates by 40% despite revenue miss amid $1.1B Teledyne acquisition.

Varex Imaging Corporation reported a strong Q3 earnings per share (EPS) of $0.31, surpassing analyst estimates of $0.21 by over 40%, signaling robust profitability. However, its revenue of $210.5 million fell slightly short of the expected $215.5 mil...

Company Fundamentals
Bullish
42 minutes ago
Par Pacific Holdings stock shows growth potential with strong financials despite recent dip.

Par Pacific Holdings stock shows growth potential with strong financials despite recent dip.

Par Pacific Holdings' stock has shown mixed performance recently, gaining 1.59% over the past 30 days but dropping 8.90% in the last 10 days. Analysts see a 9.37% growth potential with a target price of $78.80, suggesting upside from current levels. ...

Market News
Bullish
50 minutes ago
Braveheart Bio CFO buys 27,777 shares for $500K, hinting at strong IPO performance.

Braveheart Bio CFO buys 27,777 shares for $500K, hinting at strong IPO performance.

Braveheart Bio's CFO recently purchased 27,777 shares at a total cost of $500,000. This significant insider buying suggests confidence in the company's future and may indicate that the recent IPO was successful. Investors often view such insider purc...

Market News
Bullish
1 hour ago
Capital One downgrades Monday.com to Equalweight on weaker Q3 revenue outlook despite strong Q2 results.

Capital One downgrades Monday.com to Equalweight on weaker Q3 revenue outlook despite strong Q2 results.

Capital One Financial downgraded Monday.com's stock rating to Equalweight with a new price target of $95, citing Q3 revenue guidance below analyst expectations. Monday.com forecasted Q3 revenue between $368 million and $370 million, under the consens...

Analyst Insights
Bearish
1 hour ago
Amentum previews Q3 2026 earnings with $3.57B revenue forecast and nuclear project updates

Amentum previews Q3 2026 earnings with $3.57B revenue forecast and nuclear project updates

Amentum Holdings is set to report its Q3 2026 earnings on August 11, with analysts expecting $0.62 EPS and $3.57 billion in revenue. The company is involved in advanced nuclear projects, including a partnership with Rolls-Royce SMR for small modular ...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App